Literature DB >> 25303297

HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population.

Fanping Yang1, Bo Gu, Lirong Zhang, Jiekun Xuan, Heng Luo, Peng Zhou, Qinyuan Zhu, Sijia Yan, Sheng-an Chen, Zhihao Cao, Jinhua Xu, Qinghe Xing, Xiaoqun Luo.   

Abstract

AIM: Salazosulfapyridine (SASP) frequently causes several adverse reactions, such as drug rash with eosinophilia and systemic symptoms (DRESS). This study aims to assess whether there is an association between SASP-induced DRESS and HLA-A, -B and -C alleles in the Chinese Han population. SUBJECTS &
METHODS: We performed an association study of six subjects with SASP-induced DRESS, 30 SASP-tolerant patients and 283 general subjects from the human MHC database, all of whom are Han Chinese.
RESULTS: The frequency of the SASP-induced DRESS patients carrying the HLA-B*13:01 allele is 66.67% (4/6). It is significantly higher compared with the general Chinese Han population (15.19%, 43/283; odds ratio: 11.16; p = 0.007) or with the SASP-tolerant patients (13.33%, 4/30; odds ratio: 13.00; p = 0.004).
CONCLUSION: These findings show for the first time that in the Chinese Han population, HLA-B*13:01 is associated with SASP-induced DRESS. HLA-B*13:01 might serve as a potential genetic marker for reducing the prevalence of SASP-induced DRESS.

Entities:  

Keywords:  HLA-B*13:01; Han Chinese; SASP; cutaneous adverse drug reactions; salazosulfapyridine

Mesh:

Substances:

Year:  2014        PMID: 25303297     DOI: 10.2217/pgs.14.69

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  10 in total

1.  Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions.

Authors:  Kittika Yampayon; Chonlaphat Sukasem; Chanin Limwongse; Yotin Chinvarun; Therdpong Tempark; Ticha Rerkpattanapipat; Pornpimol Kijsanayotin
Journal:  Eur J Clin Pharmacol       Date:  2017-04-08       Impact factor: 2.953

2.  The Immunogenetics of Cutaneous Drug Reactions.

Authors:  Neda Khalili
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors:  Ann M Moyer; Manish J Gandhi
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

5.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

Review 6.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

Review 7.  Implementation of Pharmacogenomic Information on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Eri Tsukagoshi; Yoichi Tanaka; Yoshiro Saito
Journal:  Front Med (Lausanne)       Date:  2021-03-24

Review 8.  Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.

Authors:  Yueran Li; Pooja Deshpande; Rebecca J Hertzman; Amy M Palubinsky; Andrew Gibson; Elizabeth J Phillips
Journal:  Front Genet       Date:  2021-04-16       Impact factor: 4.599

Review 9.  An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.

Authors:  Chuang-Wei Wang; Ivan Arni C Preclaro; Wei-Hsiang Lin; Wen-Hung Chung
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 10.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.